...
首页> 外文期刊>HIV Research & Clinical Practice >Causes of hypercalcemia in people living with HIV in the HAART era
【24h】

Causes of hypercalcemia in people living with HIV in the HAART era

机译:HAART时代HIV感染者高钙血症的原因

获取原文
获取原文并翻译 | 示例

摘要

Background Hypercalcemia is an uncommon finding in people living with HIV (PLHIV). Causes of hypercalcemia in PLHIV have not been well documented. As such, we studied the causes of hypercalcemia in PLHIV. Methods We conducted a retrospective review of PLHIV who had corrected serum calcium of >= 10.5 mg/dL between 2010 and 2019. Demographic data, associated diseases, and treatment details were collected. Corrected serum calcium levels were compared among the causes of hypercalcemia. Results A total of 70 of 2168 (3.2) PLHIV had hypercalcemia. Forty-nine (70.0) were male with a mean age of 47.7 +/- 4.7 years. Only two (2.9) had symptoms of hypercalcemia. Fifty-four patients had identifiable causes of hypercalcemia; 21 infections (30.0), 17 solid organ malignancies (24.3), 14 hematologic malignancies (20.0), and two other specific causes (2.9). Mean corrected serum calcium concentrations of PLHIV who had solid organ malignancy, hematologic malignancy, infection, and unknown causes were 12.8 +/- 2.1, 11.4 +/- 1.0, 11.2 +/- 0.6, and 10.8 +/- 0.2 mg/dL, respectively. Corrected serum calcium levels were significantly greater in patients who had solid organ malignancy comparing to those with other causes of hypercalcemia (p < 0.05, all). Logistic regression identified solid organ malignancy as the only factor associated with moderate to severe hypercalcemia (odds ratio 12.72, 95 confidence interval 3.11-52.08;p < 0.001). Conclusions Hypercalcemia in PLHIV is associated with solid organ malignancy, hematologic malignancy, and infection. Most PLHIV with hypercalcemia are asymptomatic. Solid organ malignancy is associated with moderate to severe hypercalcemia, and as such PLHIV presenting with moderate to severe hypercalcemia should be investigated for solid organ malignancy.
机译:背景 高钙血症在HIV感染者(PLHIV)中并不常见。艾滋病毒感染者高钙血症的病因尚未得到充分证明。因此,我们研究了艾滋病毒感染者高钙血症的原因。方法 回顾性分析2010—2019年间血清钙>=10.5 mg/dL的PLHIV患者。收集人口统计数据、相关疾病和治疗细节。比较高钙血症病因中校正的血清钙水平。结果 2168例HIV感染者中共有70例(3.2%)存在高钙血症。49例(70.0%)为男性,平均年龄为47.7 +/- 4.7岁。只有2例(2.9%)有高钙血症症状。54例患者有可识别的高钙血症病因;感染21例(30.0%),实体器官恶性肿瘤17例(24.3%),血液系统恶性肿瘤14例(20.0%),其他特异性病因2例(2.9%)。患有实体器官恶性肿瘤、血液系统恶性肿瘤、感染和不明原因的 PLHIV 的平均校正血清钙浓度分别为 12.8 +/- 2.1、11.4 +/- 1.0、11.2 +/- 0.6 和 10.8 +/- 0.2 mg/dL。与其他原因引起的高钙血症患者相比,实体器官恶性肿瘤患者的校正血清钙水平显著升高(p < 0.05,均)。Logistic回归发现实体器官恶性肿瘤是与中度至重度高钙血症相关的唯一因素(比值比12.72,95%置信区间3.11-52.08;第<页 0.001)。结论 HIV感染者高钙血症与实体器官恶性肿瘤、血液系统恶性肿瘤和感染有关。大多数伴有高钙血症的艾滋病毒感染者是无症状的。实体器官恶性肿瘤与中度至重度高钙血症相关,因此,对于表现为中度至重度高钙血症的 PLHIV,应检查是否存在实体器官恶性肿瘤。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号